Cysteamine Bitartrate

Records for this ingredient, by country (identity only).

ATC A16AA04 · 3 markets · 9 records

Cysteamine Bitartrate 3 markets · 9 records Forms
Filters
MarketUS 6CA 2AU 1

US 6 records · 6 shown of 6 Source openFDA NDC Directory · Data as of 2026-10-23

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 75 mgcapsule · delayed-releasePROCYSBI also in US
  • 25 mgcapsule · delayed-releasePROCYSBI also in US

AU 1 records · 0 shown of 0 Source TGA CMI repository (consumer medic · Data as of live · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.